Miragen Therapeutics grants Servier worldwide rights, excluding the U.S. and Japan to microRNA-targeting products to treat cardiovascular disease

miRagen Therapeutics Inc.

U.S. / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Servier

France / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Santaris Pharma A/S

Denmark / Private Biopharma

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced